Ca2+ channel subunit a 1D promotes proliferation and migration of endometrial cancer cells mediated by 17β-estradiol via the G protein-coupled estrogen receptor

FASEB Journal

Volumn 29, Issue 7, 2015, Pages 2883-2893

  Hao, Juan ^a   Bao, Xiaoxia ^a   Jin, Bo ^b   Wang, Xiujuan ^b   Mao, Zebin ^b   Li, Xiaoping ^a   Wei, Lihui ^a   Shen, Danhua ^a   Wang, Jian Liu ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

Calcium; Cav1.3; Endometrial carcinoma; ERK1 2; Rapid signaling effect

Indexed keywords

CALCIUM CHANNEL; CALCIUM CHANNEL CAV1.3; CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL SUBUNIT ALPHA 1D; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; ESTRADIOL; ESTROGEN RECEPTOR; G PROTEIN COUPLED ESTROGEN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROGESTERONE RECEPTOR; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; ALPHA1D (CAV1.3) L-TYPE CALCIUM CHANNEL, HUMAN; CREB1 PROTEIN, HUMAN; G PROTEIN COUPLED RECEPTOR; GPER PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CANCER GRADING; CANCER STAGING; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOMETRIAL CANCER CELL LINE; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; ENDOMETRIUM POLYP; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BOVINE; CALCIUM SIGNALING; CELL MOTION; ENDOMETRIUM TUMOR; GENE SILENCING; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

BOVINAE;

ADULT; AGED; ANIMALS; CALCIUM CHANNELS, L-TYPE; CALCIUM SIGNALING; CATTLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; ESTRADIOL; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; MAP KINASE SIGNALING SYSTEM; MIDDLE AGED; RECEPTORS, ESTROGEN; RECEPTORS, G-PROTEIN-COUPLED; RNA, SMALL INTERFERING;

EID: 84940385683     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.14-265603     Document Type: Article

References (52)

1. Tashiro, H., and Katabuchi, H. (2014) The relationship between estrogen and genes in the molecular pathogenesis of endometrial carcinoma. Curr. Obstet. Gynecol. Rep. 3, 9-17
2. Siegel, R., Naishadham, D., and Jemal, A. (2013) Cancer statistics, 2013. CA Cancer J. Clin. 63, 11-30
3. Coiret, G., Matifat, F., Hague, F., and Ouadid-Ahidouch, H. (2005) 17-beta-estradiol activates maxi-K channels through a non-genomic pathway in human breast cancer cells. FEBS Lett. 579, 2995-3000
4. Guo, R. X., and Wei., L. H., Tu, Z., Sun, P. M., Wang, J. L., Zhao, D., Li, X. P., and Tang, J. M. (2006) 17 beta-estradiol activates PI3K/Akt signaling pathway by estrogen receptor (ER)-dependent and ER-independent mechanisms in endometrial cancer cells. J. Steroid Biochem. Mol. Biol. 99, 9-18
5. Platet, N., and Cathiard., A. M., Gleizes, M., and Garcia, M. (2004) Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion. Crit. Rev. Oncol. Hematol. 51, 55-67
6. Huang, J., Li, X., Yi, P., Hilf, R., Bambara, R.A., and Muyan, M. (2004) Targeting estrogen responsive elements (EREs): design of potent transactivators for ERE-containing genes. Mol. Cell. Endocrinol. 218, 65-78
7. Skrzypczak, M., Schüler, S., Lattrich, C., Ignatov, A., Ortmann, O., and Treeck, O. (2013) Gprotein-coupled estrogen receptor (GPER) expressioninendometrial adenocarcinoma andeffectofagonist G-1 on growth of endometrial adenocarcinoma cell lines. Steroids 78, 1087-1091
8. Pedram, A., Razandi, M., and Levin, E. R. (2006) Nature of functional estrogen receptors at the plasma membrane. Mol. Endocrinol. 20, 1996-2009
9. Tsai, C. L., and Wu., H. M., Lin, C. Y., Lin, Y. J., Chao, A., Wang, T. H., Hsueh, S., Lai, C.H., and Wang, H.S. (2013) Estradiol and tamoxifen induce cell migration through GPR30 and activation of focal adhesion kinase (FAK) in endometrial cancers with low or without nuclear estrogen receptor a (ERa). PLoS ONE 8, e72999
10. Watson, C. S. (1999) Signaling themes shared between peptide and steroid hormones at the plasma membrane. Sci. STKE 1999, PE1
11. Bulayeva, N. N., and Wozniak., A. L., Lash, L. L., and Watson, C. S. (2005) Mechanisms of membrane estrogen receptor-alpha-mediated rapid stimulation of Ca2+ levels and prolactin release in a pituitary cell line. Am. J. Physiol. Endocrinol. Metab. 288, E388-E397
12. English, J., Pearson, G., Wilsbacher, J., Swantek, J., Karandikar, M., Xu, S., and Cobb, M.H. (1999) New insights into the control of MAP kinase pathways. Exp. Cell Res. 253, 255-270
13. Bulayeva, N.N., Gametchu, B., and Watson, C.S. (2004) Quantitative measurement of estrogen-induced ERK 1 and 2 activation via multiple membrane-initiated signaling pathways. Steroids 69, 181-192
14. Doolan, C. M., and Condliffe., S. B., and Harvey, B. J. (2000) Rapid non-genomicactivationofcytosolic cyclicAMP-dependent protein kinase activity and [Ca(2+)](i) by 17beta-oestradiol in female rat distal colon. Br. J. Pharmacol. 129, 1375-1386
15. Losel, R. M., Falkenstein, E., Feuring, M., Schultz, A., and Tillmann., H. C., Rossol-Haseroth, K., and Wehling, M. (2003) Nongenomic steroid action: controversies, questions, and answers. Physiol. Rev. 83, 965-1016
16. Prevarskaya, N., Skryma, R., and Shuba, Y. (2011) Calciumintumour metastasis: new roles for known actors. Nat. Rev. Cancer 11, 609-618
17. Cain, S.M., and Snutch, T. P. (2011) Voltage-gated calciumchannels and disease. Biofactors 37, 197-205
18. Berridge, M. J. (2012) Calcium signalling remodelling and disease. Biochem. Soc. Trans. 40, 297-309
19. Engh, A., Somasundaram, A., and Prakriya, M. (2012) Permeation and gating mechanisms in store-operated CRAC channels. Front. Biosci. (Landmark Ed.) 17, 1613-1626
20. Buraei, Z., and Yang, J. (2010) The b subunit of voltage-gated Ca2+ channels. Physiol. Rev. 90, 1461-1506
21. Murphy, T. H., and Worley., P. F., and Baraban, J. M. (1991) L-type voltage-sensitive calcium channels mediate synaptic activation of immediate early genes. Neuron 7, 625-635
22. Marshall, J., and Dolan., B. M., Garcia, E. P., Sathe, S., Tang, X., Mao, Z., and Blair, L. A. (2003) Calcium channel and NMDA receptor activities differentially regulate nuclear C/EBPbeta levels to control neuronal survival. Neuron 39, 625-639
23. Reinbothe, T. M., Alkayyali, S., Ahlqvist, E., Tuomi, T., Isomaa, B., Lyssenko, V., and Renström, E. (2013) The human L-type calcium channel Cav1.3 regulates insulin release and polymorphisms in CACNA1D associate with type 2 diabetes. Diabetologia 56, 340-349
24. Chen, R., Zeng, X., Zhang, R., Huang, J., Kuang, X., Yang, J., Liu, J., Tawfik, O., Thrasher, J. B., and Li, B. (2014) Cav1.3 channel α1D protein is overexpressed and modulates androgen receptor transactivation in prostate cancers. Urol. Oncol. 32, 524-536
25. Zhang, L., Li, X., Zhao, L., Zhang, L., Zhang, G., Wang, J., and Wei, L. (2009) Nongenomic effect of estrogen on the MAPK signaling pathway and calcium influx in endometrial carcinoma cells. J. Cell. Biochem. 106, 553-562
26. Bao, X. X., and Wang., J. L., and Wei, L. H. (2012) [Impact of calcium channel antagonists for estrogen action on the endometrial carcinoma HEC-1A cells]. Zhonghua Fu Chan Ke Za Zhi 47, 212-217
27. Sun, L., Wang, J., Zhang, L., Li, X., and Shen, D. (2013) Expression of ER-a36, a novel variant of estrogen receptor in endometrial carcinoma and its clinical significance. Gynecol. Obstet. Invest. 75, 68-72
28. Bao, X. X., and Xie., B. S., Li, Q., Li, X. P., Wei, L. H., and Wang, J. L. (2012) Nifedipine induced autophagy through Beclin1 and mTOR pathway in endometrial carcinoma cells. Chin. Med. J. (Engl.) 125, 3120-3126
29. Naguro, I., Adachi-Akahane, S., and Ichijo, H. (2004) Calcium signaling via voltage-dependent L-type Ca2+ channels. Signal Transduct. 4, 195-205
30. Smith, H. O., and Leslie., K. K., Singh, M., Qualls, C. R., Revankar, C. M., Joste, N. E., and Prossnitz, E. R. (2007) GPR30: a novel indicator of poor survival for endometrial carcinoma. Am. J. Obstet. Gynecol. 196, 381-389
31. Wu, T. W., and Wang., J. M., Chen, S., and Brinton, R. D. (2005) 17Beta-estradiol induced Ca2+ influx via L-type calcium channels activates the Src/ERK/cyclic-AMP response element binding protein signal pathway and BCL-2 expression in rat hippocampal neurons: a potential initiation mechanism for estrogen-induced neuroprotection. Neuroscience 135, 59-72
32. Sarkar, S. N., and Huang., R. Q., Logan, S. M., Yi, K. D., Dillon, G. H., and Simpkins, J. W. (2008) Estrogens directly potentiate neuronal L-type Ca2+ channels. Proc. Natl. Acad. Sci. USA 105, 15148-15153
33. Boulware, M. I., and Weick., J. P., Becklund, B. R., Kuo, S. P., Groth, R. D., and Mermelstein, P. G. (2005) Estradiol activates group I and II metabotropic glutamate receptor signaling, leading to opposing influences on cAMP response element-binding protein. J. Neurosci. 25, 5066-5078
34. Ullrich, N. D., Koschak, A., and MacLeod, K. T. (2007) Oestrogen directly inhibits the cardiovascular L-type Ca2+ channel Cav1.2. Biochem. Biophys. Res. Commun. 361, 522-527
35. Perret, S., Dockery, P., and Harvey, B. J. (2001) 17beta-oestradiol stimulates capacitative Ca2+ entry in human endometrial cells. Mol. Cell. Endocrinol. 176, 77-84
36. Brewer, L.D., Dowling, A.L., Curran-Rauhut, M.A., Landfield, P. W., and Porter., N. M., and Blalock, E. M. (2009) Estradiol reversesa calcium-related biomarker of brain aging in female rats. J. Neurosci. 29, 6058-6067
37. Watters, J. J., and Campbell., J. S., Cunningham, M. J., Krebs, E. G., and Dorsa, D. M. (1997) Rapid membrane effects of steroids in neuroblastoma cells: effects of estrogen on mitogen activated protein kinase signalling cascade and c-fos immediate early gene transcription. Endocrinology 138, 4030-4033
38. Duan, R., Xie, W., Burghardt, R. C., and Safe, S. (2001) Estrogen receptor-mediated activation of the serum response element in MCF-7 cells through MAPK-dependent phosphorylation of Elk-1. J. Biol. Chem. 276, 11590-11598
39. Giordano, T. P., Tropea, T.F., Satpute, S.S., Sinnegger-Brauns, M. J., Striessnig, J., Kosofsky, B. E., and Rajadhyaksha, A. M. (2010) Molecular switch from L-type Ca v 1.3 to Ca v 1.2 Ca2+ channel signaling underlies long-term psychostimulant-induced behavioral and molecular plasticity. J. Neurosci. 30, 17051-17062
40. Gao, L., and Blair., L. A., Salinas, G. D., Needleman, L. A., and Marshall, J. (2006) Insulin-like growth factor-1 modulation of CaV1.3 calcium channels depends on Ca2+ release from IP3-sensitive stores and calcium/calmodul in kinase II phosphorylation of the alpha1 subunit EF hand. J. Neurosci. 26, 6259-6268
41. Olson, S. H., and Atoria., C. L., Cote, M. L., Cook, L. S., Rastogi, R., Soslow, R. A., Brown, C. L., and Elkin, E. B. (2012) The impact of race and comorbidity on survival in endometrial cancer. Cancer Epidemiol. Biomarkers Prev. 21, 753-760
42. Saltzman, B.S., Doherty, J. A., Hill, D.A., Beresford, S.A., Voigt, L.F., Chen, C., and Weiss, N. S. (2008) Diabetes and endometrial cancer: an evaluation of the modifying effects of other known risk factors. Am. J. Epidemiol. 167, 607-614
43. Kunzelmann, K. (2005) Ion channels and cancer. J. Membr. Biol. 205, 159-173
44. Bertolesi, G. E., Shi, C., Elbaum, L., Jollimore, C., Rozenberg, G., Barnes, S., and Kelly, M. E. (2002) The Ca(2+) channel antagonists mibefradil and pimozide inhibit cell growth via different cytotoxic mechanisms. Mol. Pharmacol. 62, 210-219
45. Gackière, F., Bidaux, G., Delcourt, P., Van Coppenolle, F., Katsogiannou, M., Dewailly, E., Bavencoffe, A., Van Chuöi-Mariot, M. T., Mauroy, B., Prevarskaya, N., and Mariot, P. (2008) CaV3.2 T-type calcium channels are involved in calcium-dependent secretion of neuroendocrine prostate cancer cells. J. Biol. Chem. 283, 10162-10173
46. Haverstick, D. M., and Heady., T. N., Macdonald, T. L., and Gray, L. S. (2000) Inhibition of human prostate cancer proliferation in vitro and in a mouse model by a compound synthesized to block Ca2+ entry. Cancer Res. 60, 1002-1008
47. Latour, I., and Louw., D. F., Beedle, A. M., Hamid, J., Sutherland, G. R., and Zamponi, G. W. (2004) Expression of T-type calcium channel splice variants in human glioma. Glia 48, 112-119
48. Shapovalov, G., Skryma, R., and Prevarskaya, N. (2013) Calcium channels and prostate cancer. Recent Patents Anticancer. Drug Discov. 8, 18-26
49. Taylor, J. T., Huang, L., Pottle, J. E., Liu, K., Yang, Y., Zeng, X., Keyser, B. M., Agrawal, K. C., Hansen, J. B., and Li, M. (2008) Selective blockade of T-type Ca2+ channels suppresses human breast cancer cell proliferation. Cancer Lett. 267, 116-124
50. Maggiolini, M., Vivacqua, A., Fasanella, G., Recchia, A. G., Sisci, D., Pezzi, V., Montanaro, D., Musti, A.M., Picard, D., and Andò, S. (2004) The Gprotein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells. J. Biol. Chem. 279, 27008-27016
51. Albanito, L., Madeo, A., Lappano, R., Vivacqua, A., Rago, V., Carpino, A., Oprea, T. I., Prossnitz, E. R., Musti, A. M., Andò, S., and Maggiolini, M. (2007) G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells. Cancer Res. 67, 1859-1866
52. Vivacqua, A., Bonofiglio, D., Recchia, A. G., Musti, A. M., Picard, D., Andò, S., and Maggiolini, M. (2006) TheGprotein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells. Mol. Endocrinol. 20, 631-646